Ventricular Fibrillation Due to Lithium Withdrawal--an Interaction with Chlorpromazine?
Overview
Overview
Journal
Postgrad Med J
Publisher
Oxford University Press
Specialty
General Medicine
Date
1989 Dec 1
PMID
2616436
Citations
1
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
We report a case of primary ventricular fibrillation following withdrawal of lithium in a patient concurrently taking chlorpromazine. A potentially important drug interaction is discussed.
Citing Articles
Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.
Brown C, Farmer R, Soberman J, Eichner S Clin Pharmacokinet. 2004; 43(1):33-56.
PMID: 14715050 DOI: 10.2165/00003088-200443010-00003.
References
1.
HUSTON J, Bell G
. The effect of thioridazine hydrochloride and chlorpromazine on the electrocardiogram. JAMA. 1966; 198(1):134-8.
DOI: 10.1001/jama.198.1.134.
View
2.
Alexander C, Nino A
. Cardiovascular complications in young patients taking psychotropic drugs. A preliminary report. Am Heart J. 1969; 78(6):757-69.
DOI: 10.1016/0002-8703(69)90442-6.
View
3.
FOWLER N, McCall D, Chou T, Holmes J, HANENSON I
. Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol. 1976; 37(2):223-30.
DOI: 10.1016/0002-9149(76)90316-7.
View
4.
Nasrallah H, Strauss J, Lasagna L
. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. Am J Psychiatry. 1976; 133(6):646-52.
DOI: 10.1176/ajp.133.6.646.
View
5.
. Effect of lithium on gastric emptying and absorption of oral chlorpromazine. Psychopharmacol Commun. 1976; 2(3):263-72.
View